Rare lephants
Screener

CASI Pharmaceuticals, Inc.

CASIF ·Healthcare, Drug Manufacturers - General, China
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
6-K Sep 2, 2026 FORM 6-K
6-K Aug 14, 2026 FORM 6-K
6-K Aug 13, 2026 FORM 6-K
6-K Jul 15, 2026 FORM 6-K
6-K Jun 29, 2026 FORM 6-K
25-NSE Jun 23, 2026
6-K Jun 2, 2026 FORM 6-K
SCHEDULE 13D/A May 18, 2026
20-F May 15, 2026 20-F
D Apr 28, 2026
3 Apr 23, 2026 OWNERSHIP DOCUMENT
NT 20-F Apr 21, 2026 NT 20-F
3 Apr 20, 2026 OWNERSHIP DOCUMENT
6-K Apr 20, 2026 FORM 6-K
6-K Apr 20, 2026 FORM 6-K
3 Apr 16, 2026 OWNERSHIP DOCUMENT
6-K Apr 15, 2026 FORM 6-K
3 Apr 13, 2026 OWNERSHIP DOCUMENT
3 Apr 7, 2026 OWNERSHIP DOCUMENT
3 Apr 3, 2026 OWNERSHIP DOCUMENT
3 Apr 3, 2026 OWNERSHIP DOCUMENT
3 Mar 27, 2026 OWNERSHIP DOCUMENT
3 Mar 25, 2026 OWNERSHIP DOCUMENT
SCHEDULE 13D/A Mar 23, 2026
3 Mar 18, 2026 OWNERSHIP DOCUMENT
← Newer Page 1 of 7 · 157 filings Older →